At 2:41 a.m., someone “pulls” a vial of a controlled medication from the pharmacy/med room.
At 2:44 a.m., the patient still doesn’t have a digital physician order linked to them.
At 3:10 a.m., a dose “adjustment” shows up, a “return” gets mentioned… or nothing shows up at all.
By month-end, inventory almost reconciles—but your margin doesn’t. And the explanation usually becomes a cocktail of three ghosts: shrinkage, errors, and petty theft (“leakage”).
A quick clarification: the “15%” is not a universal, one-size-fits-all loss rate—and itshouldn’t be treated as one. But it’s a useful provocation: some estimates suggest 10–15% of healthcare workers may engage in drug diversion at least once in their career. (LAPPA)
And when the system lacks clear traceability, “missing inventory” turns into emotional accounting: “it just disappears.”
The angle: shrink control and “small leaks” (when nobody’s watching—and when everyone’s busy)
Hospital pharmacy is a complex system with risk points at every step: prescribing, verification, dispensing, transfer, administration, returns, and waste. That’s why The Joint Commission flags drug diversion as a serious threat to patient safety—plus a legal, regulatory, and reputational risk for organizations.
(digitalassets.jointcommission.org)
In parallel, reviews on controlled-substance diversion in hospitals describe multiple diversion methods and emphasize the need for safeguards because historically, many hospitals have struggled to fully “account for” losses. (shmpublications.onlinelibrary.wiley.com)
Translation: this isn’t paranoia. It’s governance.
The thesis: the disconnect between prescribing and dispensing is a financial black hole
When prescribing lives in one world and dispensing/inventory lives in another, you create the perfect conditions for:
- “temporary” removals that never come back
- last-minute changes with no clean trail
- returns documented “in bulk” (or not at all)
- waste without dual validation
- discrepancies that never get closed (“no one has time”)
ASHP and ISMP have been pushing the same message for years: for controlled substances and high-risk medications, you need access controls, discrepancy reconciliation, perpetual inventory, counts, and reporting supported by technology (e.g., automated dispensing cabinets and reconciliation processes). (ashp.org)
And when the workflow breaks, operational signals show up. For example, studies on automated dispensing workflows suggest that the longer the time between medication removal and documentation/reconciliation, the higher the risk—and the higher the administrative cost of audits. (PMC)
The “Bermuda Triangle” (hospital edition)
Think of three vertices where inventory tends to “evaporate”:
1) Prescribing
- verbal orders, paper, delayed entry
- frequent changes without traceability
- incomplete orders (no patient link, no dose, no justification)
2) Dispensing
- medication leaves without a digital order linkage
- returns not recorded (or recorded in batches)
- discrepancies normalized as “how it is”
3) Administration (the most expensive blind spot)
- waste without validation
- administration documented late (or differently than what was removed)
- substitutions “due to availability” without a complete clinical trail
The goal isn’t to hunt for villains. It’s to redesign the system so it’s hard to do the wrong thing and easy to do the right thing.
The financial autopsy: how to spot the leak before it becomes “normal loss”
A digital hospital doesn’t wait for a monthly physical count to find out.
It looks for patterns, for example:
- medications with a high “correction/adjustment” rate
- removals without administration documentation within a reasonable time
- recurring discrepancies by shift/unit/user
- returns without inventory reintegration
- waste outside expected norms
This is already happening with analytics: research shows how consolidated datasets and analytical models can accelerate diversion detection compared to traditional methods. (PMC)
Translation: when you connect the data, you stop chasing ghosts and start chasing signals.
The strategic move: “nothing leaves without an order” and “everything is traceable”
Here’s the operating principle that changes the game:
Nothing leaves the pharmacy unless there’s a digital medical order linked to a specific patient.
And every movement leaves a footprint: who, what, how much, when, where, and why.
That becomes possible when prescribing, inventory, and dispensing are integrated, and when your “electronic Kardex” (patient-level dispensing and administration tracking) is tied to real-time inventory with reconciliation and auditability.
ASHP and ISMP guidelines support technology + processes for perpetual inventory, discrepancy resolution, and stronger controls especially for controlled substances. (ashp.org)
Where HarmoniMD fits: from “loose withdrawals” to clinical-financial traceability
HarmoniMD HIS: pharmacy + inventory + dispensing in the same ecosystem
HarmoniMD describes integrated capabilities for pharmacy and medication administration, including inventory control and dispensing. (Harmoni MD)
Harmoni-Go: integrated e-prescribing + reporting
Harmoni-Go’s Pharmacy module positions integrated e-prescriptions, inventory control, and consumption/cost reporting for operational decision-making. (Harmoni-Go)
In practice, the objective is simple:
- digital order → dispensing → Kardex/evidence → inventory
- no gaps between modules
- reporting that highlights discrepancies and trends (not just “stock levels”)
CLARA: less time searching, more time controlling
In an integrated environment, CLARA can speed up review and analysis (patient context, change history, patterns by medication/unit), reducing the “human cost” of manual audits and helping shift from reaction to prevention especially when data is structured inside the HIS.
Conclusion: “petty theft” isn’t just behavior—it’s system design
Diversion and shrinkage don’t get solved with a stern memo and a policy reminder.
They get solved by closing the black hole: the disconnect between a clinical order and an inventory-out transaction.
The standards exist for a reason: perpetual inventory, discrepancy reconciliation, auditability, and technology-supported controls are part of the modern playbook. (ashp.org)
And diversion risk is serious enough that The Joint Commission frames it as a patient safety and organizational risk issue. (digitalassets.jointcommission.org)
Book a demo and close your “Bermuda Triangle”
If you want to see how HarmoniMD (HIS) + Harmoni-Go + CLARA can help ensure nothing leaves the pharmacy without a linked digital order, with traceability and automated reporting to detect shrink/diversion patterns—book a demo. book a demo.